LEADER 02130nam  2200373   450 
001 9910633974103321
005 20230326220034.0
010   $a1-80355-376-6
035   $a(CKB)5700000000338619
035   $a(NjHacI)995700000000338619
035   $a(EXLCZ)995700000000338619
100   $a20230326d2022      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPsoriasis $eNew Research /$fShahin Aghaei
210  1$aLondon :$cIntechOpen,$d2022.
215   $a1 online resource (198 pages)
311   $a1-80355-375-8 
327   $a1. The Clinical Characteristics and Treatment Status of Psoriatic Arthritis -- 2. Dermoscopic Differential Diagnosis of Psoriasis -- 3. Psoriasis and Skin Comorbidities -- 4. Th17/IL-17, Immunometabolism and Psoriatic Disease: A Pathological Trifecta -- 5. Immune Markers in Psoriasis -- 6. Immunomodulatory Effect of Methotrexate Abruptly Controls Keratinocyte Activation in Psoriasis -- 7. Topical Moisturisers for the Management of Psoriasis Vulgaris -- 8. Developing Novel Molecular Targeted Therapeutics for Topical Treatment of Psoriasis.
330   $aPsoriasis is a chronic skin disease that starts with lesions that appear red, thick, scaly, and itchy with bilateral and symmetrical distribution. The lesions are most often seen in the scalp, elbows, knees, and genitalia. The extent of the lesions is not always limited to these areas, and in some cases, it may involve larger parts of the skin, as well as nails and joints in some cases. This book presents a comprehensive overview of psoriasis, including clinical aspects, differential diagnosis by dermoscopic devices, comorbidities, immune system changes, methotrexate therapy, and topical innovative molecular targeted therapeutics.
517   $aPsoriasis 
606   $aPsoriasis
615  0$aPsoriasis.
676   $a616.52606
700   $aAghaei$b Shahin$01348884
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910633974103321
996   $aPsoriasis$93086575
997   $aUNINA